Communiqués Inotiv, Inc.

Actions

NOTVQ

US45783Q1004

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets Autres places de cotation 21:33:31 17/07/2026			Varia. 5j.	Varia. 1 janv.
0,0111 ^USD	-26,00%		0,00%	-98,03%

15/07	Inotiv obtient l'homologation de son plan de réorganisation par le tribunal	MT
08/06	Les plus fortes baisses en préouverture	MT

Communiqués

03/06	Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth	BU
13/02	Inotiv Provides Notice Regarding Cybersecurity Incident	AQ
09/02	Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update	AQ
04/02	Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026	AQ
13/01	Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery	AQ
11/12	Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities	AQ
10/12	Inotiv : Investor Presentation December 2025	PU
05/12	Inotiv : Annual Report for Fiscal Year Ending September 30, 2025 (Form 10-K)	PU
03/12	Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update	AQ
25/11	Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™	AQ
21/11	Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025	AQ
17/11	Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results	AQ
21/10/25	Inotiv, Inc. to Participate in Three Investor Conferences in November 2025	AQ
13/08/25	Inotiv, Inc. to Participate in Three Investor Conferences in September 2025	AQ
07/08/25	CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update	AQ
06/08/25	Inotiv : Third Quarter 2025 Earnings Release	PU
06/08/25	Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update	AQ
23/07/25	Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025	AQ
17/06/25	Inotiv : Code of Business Conduct and Ethics (Global Code of Business Conduct and Ethics Web Version FINAL bbb831)	PU
22/05/25	Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025	AQ
07/05/25	Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update	AQ
23/04/25	Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025	AQ
07/04/25	Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders	AQ
05/02/25	Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update	AQ
22/01/25	Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025	AQ